TRIM33: A Potential Drug Target for Tissue Development and Maintenance

Target Name: TRIM33

NCBI ID: G51592

TRIM33

TRIM33: A Potential Drug Target for Tissue Development and Maintenance

TRIM33 (TIF1GAMMA) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues.

One of the unique features of TRIM33 is its ability to induce a state of cell-contact in cells, known as a "contact-induced proliferation" (contact-induced proliferation). This allows scientists to study the effects of drugs on cell growth and behavior, and has led to the development of TRIM33 as a potential drug target.

In addition to its role in cell growth and differentiation, TRIM33 is also involved in the regulation of cell-cell interactions and in the development of tissues. It has been shown to play a key role in the development of tissues such as the gut, and is involved in the regulation of processes such as cell migration and the formation of tissues.

TRIM33 is also involved in the regulation of cellular signaling, including the TGF-β pathway. This pathway is involved in pathways in the regulation of cell growth, differentiation, and survival, and is a key factor in the development and maintenance of tissues.

TRIM33 is a protein that is expressed in various tissues throughout the body, and is involved in the regulation of cell growth and differentiation. Its unique ability to induce cell-contact and its involvement in the TGF-β pathway make it a potential drug target. Further research is needed to fully understand the role of TRIM33 in tissue development and maintenance, and to develop effective treatments for TRIM33-related diseases.

Protein Name: Tripartite Motif Containing 33

Functions: Acts as an E3 ubiquitin-protein ligase. Promotes SMAD4 ubiquitination, nuclear exclusion and degradation via the ubiquitin proteasome pathway. According to PubMed:16751102, does not promote a decrease in the level of endogenous SMAD4. May act as a transcriptional repressor. Inhibits the transcriptional response to TGF-beta/BMP signaling cascade. Plays a role in the control of cell proliferation. Its association with SMAD2 and SMAD3 stimulates erythroid differentiation of hematopoietic stem/progenitor (By similarity). Monoubiquitinates SMAD4 and acts as an inhibitor of SMAD4-dependent TGF-beta/BMP signaling cascade (Monoubiquitination of SMAD4 hampers its ability to form a stable complex with activated SMAD2/3 resulting in inhibition of TGF-beta/BMP signaling cascade)

The "TRIM33 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRIM33 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets